| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Oct 2025 | 3 Oct 2025 |
| Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday 9th October 2025 Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 ,inter alia, to consider and approve With reference to our earlier intimation dated 3rd October, 2025 regarding the meeting of the Board of Directors of the Company scheduled to be held on today, Thursday, 9th October, 2025 at 4:00 P.M., we wish to inform you that due to unavoidable circumstances, the said meeting has been rescheduled to Friday, 10th October, 2025 at 4:00 P. M. at the registered office of the Company i.e. A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380 060, inter alia, to consider and approve: 1. The Unaudited Financial Results of the Company for the Half Year ended on 30th September, 2025 along with Limited Review Report. 2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. Kindly take the same on your record and oblige us. (As Per BSE Announcement Dated on:09.10.2025) Outcome of Board Meeting hel today i.e. 10th October 2025 (As per BSE Announcement dated on: 10.10.2025) | ||
| Board Meeting | 26 Aug 2025 | 26 Aug 2025 |
| Outcome of the Board Meeting held on 26th August, 2025. | ||
| Board Meeting | 21 Aug 2025 | 21 Aug 2025 |
| Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting held today i.e., Thursday, 21st August, 2025, at the registered office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 07:00 P.M. and concluded at 07:30 P.M., has inter alia, reviewed and decided to withdraw the proposals for preferential issue of equity shares, which were earlier approved by the Board at its meeting held on 29th April, 2025, In view of change in market conditions and a strategic realignment, the Board has decided to withdraw the above-mentioned preferential issue proposals in connection with the proposed acquisitions of M/s. Poshan Nutriwell Private Limited and M/s. Spazio Formulations Limited. Intimation for Withdrawal of proposed preferential issue. | ||
| Board Meeting | 7 Jun 2025 | 7 Jun 2025 |
| Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., 7th June, 2025 at the Registered office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 04:30 P.M. and concluded at 05:00 P.M. has considered and approved appointment of Ms. Nikita Jain (Membership No: A25156) as Company Secretary and Compliance Officer of the Company w.e.f. 7th June, 2025. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.